Latest News

Date Title Topic
10 Jul 2017 First-Line Nivolumab in Stage IV or Recurrent NSCLC with a PD-L1 Expression Level of 5% or More Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
07 Jul 2017 FDA Grants Marketing Approval to the Praxis Extended RAS Panel Personalised medicine - Anticancer agents & Biologic therapy
06 Jul 2017 NICE Develops a Medtech Innovation Briefing on L-Dex U400 for Lymphoedema After Breast Cancer Treatment Breast cancer - Diagnosis, Imaging and Staging
05 Jul 2017 Metastatic Colorectal Cancer: Beyond RAS and BRAF Translational research - Gastrointestinal cancers
Congress Scarf Contest
04 Jul 2017 EMA Recommends Extension of Indications for Fulvestrant Breast cancer - Anticancer agents & Biologic therapy
04 Jul 2017 ESMO/ACF Patient Guide in Gliomas Now Available Also in French
eUpdate – Treatment Recommendation
03 Jul 2017 ESMO/ACF Patient Guide in Soft Tissue Sarcomas Now Available Also in Japanese
03 Jul 2017 FDA Approves Betrixaban for the Prophylaxis of VTE in Adult Patients Palliative and supportive care
01 Jul 2017 World GI 2017 Press Release: Right-sided Colorectal Tumours: An Internal Radiation Advantage Gastrointestinal cancers
30 Jun 2017 ESMO/ACF Patient Guide in Cervical Cancer Now Available Also in Serbian
30 Jun 2017 ESMO/ACF Patient Guide in Bone Sarcoma Now Also Available in French
30 Jun 2017 ESMO/ACF Patient Guide in Sarcoma Now Available Also in Spanish
30 Jun 2017 FDA Approves Rituximab Plus Hyaluronidase Combination for Treatment of FL, DLBCL and CLL Haematologic malignancies - Anticancer agents & Biologic therapy